SpringWorks Therapeutics Inc (NASDAQ: SWTX) on Tuesday, plunged -0.02% from the previous trading day, before settling in for the closing price of $46.97. Within the past 52 weeks, SWTX’s price has moved between $28.21 and $62.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -24.25%. The company achieved an average annual earnings per share of 20.99%. With a float of $72.94 million, this company’s outstanding shares have now reached $74.99 million.
Let’s determine the extent of company efficiency that accounts for 368 employees. In terms of profitability, gross margin is 93.23%, operating margin of -120.52%, and the pretax margin is -115.6%.
SpringWorks Therapeutics Inc (SWTX) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of SpringWorks Therapeutics Inc is 3.19%, while institutional ownership is 98.04%. The most recent insider transaction that took place on Mar 03 ’25, was worth 1,084,592. In this transaction Chief Operating Officer of this company sold 20,000 shares at a rate of $54.23, taking the stock ownership to the 169,712 shares. Before that another transaction happened on Mar 03 ’25, when Company’s Chief Executive Officer sold 49,000 for $54.24, making the entire transaction worth $2,657,656. This insider now owns 954,869 shares in total.
SpringWorks Therapeutics Inc (SWTX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 20.99% per share during the next fiscal year.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Trading Performance Indicators
SpringWorks Therapeutics Inc (SWTX) is currently performing well based on its current performance indicators. A quick ratio of 4.18 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 16.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.41, a number that is poised to hit -0.80 in the next quarter and is forecasted to reach -0.83 in one year’s time.
Technical Analysis of SpringWorks Therapeutics Inc (SWTX)
Looking closely at SpringWorks Therapeutics Inc (NASDAQ: SWTX), its last 5-days average volume was 5.66 million, which is a jump from its year-to-date volume of 4.17 million. As of the previous 9 days, the stock’s Stochastic %D was 81.72%.
During the past 100 days, SpringWorks Therapeutics Inc’s (SWTX) raw stochastic average was set at 48.44%, which indicates a significant decrease from 82.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.15% in the past 14 days, which was lower than the 72.25% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $45.11, while its 200-day Moving Average is $41.04. However, in the short run, SpringWorks Therapeutics Inc’s stock first resistance to watch stands at $46.97. Second resistance stands at $46.98. The third major resistance level sits at $46.99. If the price goes on to break the first support level at $46.95, it is likely to go to the next support level at $46.94. Should the price break the second support level, the third support level stands at $46.93.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Key Stats
Market capitalization of the company is 3.54 billion based on 75,349K outstanding shares. Right now, sales total 191,590 K and income totals -258,130 K. The company made 49,090 K in profit during its latest quarter, and -83,190 K in sales during its previous quarter.
